PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 15, 1999Circulation439 citationsOpen Access

Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in Mice

View Full Paper
LRLuís Eduardo Paim RohdeADAnique DucharmeLALuis H. Arroyo

Structured PICO

Does a broad-spectrum MMP inhibitor attenuate early left ventricular enlargement after experimental myocardial infarction in mice?

P
Population
71 male FVB mice that survived ligation of the left anterior coronary artery (experimental myocardial infarction)
I
Intervention
Broad-spectrum MMP inhibitor (CP-471,474) administered by gavage
C
Comparator
Placebo administered by gavage
O
Outcome
Changes in end-systolic and end-diastolic dimensions and areas at midpapillary and apical levels measured by echocardiography at 4 dayssurrogate

Inhibition of matrix metalloproteinases attenuates early left ventricular dilation and preserves fractional shortening after experimental myocardial infarction in mice.

Abstract

BACKGROUND: Extracellular matrix synthesis and degradation contribute to the morphological changes that occur after myocardial infarction (MI). METHODS AND RESULTS: We tested the hypothesis that inhibition of matrix metalloproteinases (MMPs) attenuates left ventricular remodeling in experimental MI. Seventy-one male FVB mice that survived ligation of the left anterior coronary artery were randomized to a broad-spectrum MMP inhibitor (CP-471,474) or placebo by gavage. Echocardiographic studies were performed before randomization (within 24 hours of surgery) and 4 days later and included short-axis imaging at the midpapillary and apical levels. Infarction as defined by wall motion abnormality was achieved in 79% of the procedures (n=56), and mortality rate during the 4-day protocol was 23% (9 of 36 on treatment vs 7 of 35 on placebo; P=NS). Baseline end-diastolic and end-systolic dimensions and areas were similar (P=NS) between treated and placebo groups. At follow-up, infarcted mice allocated to MMP inhibitor had significantly smaller increases in end-systolic and end-diastolic dimensions and areas at both midpapillary and apical levels compared with infarcted mice allocated to placebo (all P<0.05). In addition, infarcted animals that received MMP inhibitor had no change in fractional shortening (-3+/-13%), whereas animals that received placebo had a decrease in fractional shortening (-12+/-12%) (P<0.05). In an analysis stratified by baseline end-diastolic area, the effects of MMP inhibition on the changes in end-systolic area and end-diastolic area were most prominent in animals that had more initial left ventricular dilatation (both P<0.05). CONCLUSIONS: -Administration of an MMP inhibitor attenuates early left ventricular dilation after experimental MI in mice. Further studies in genetically altered mice and other models will improve understanding of the role of MMPs in left ventricular remodeling.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rohde et al. (1999) studied this question.

synapsesocial.com/papers/69f53f53e0fbb6efbd203976https://doi.org/10.1161/01.cir.99.23.3063
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.1990 · 2,877 citations
  2. 2Echocardiographic and cardiac doppler assessment of mice1995 · 114 citations
  3. 3Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.1993 · 318 citations
  4. 4Myocardial ischemia and reperfusion: a murine model1995 · 434 citations
  5. 5Murine Cardiac Function1998 · 178 citations